Medical Equipment

Drug Delivery Devices Market Size and Demand Forecast 2026–2030

February 4, 2026February 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Drug Delivery Devices Market show for the 2026–2030 period?

The drug delivery devices market has demonstrated robust expansion recently. This market is projected to expand from $95.99 billion in 2025 to $102.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.4%. Historically, this growth has been driven by factors such as the increasing occurrence of chronic illnesses, the broader adoption of injectable treatments, an increase in hospital-based drug management, the growing application of infusion devices, and innovations in pharmaceutical preparations.

The market for drug delivery devices is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $128.94 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.0%. Several factors are contributing to this growth during the forecast period, including the increased uptake of home-based drug administration, rising capital outlays in personalized medicine, the broadening scope of biologics and biosimilars, an escalating need for connected delivery systems, and the greater incorporation of digital health platforms. Key developments expected in the same period involve a heightened acceptance of smart drug delivery devices, the growing implementation of self-administration injection mechanisms, an increasing requirement for controlled release technologies, the expansion of wearable drug delivery platforms, and a reinforced emphasis on patient-centered designs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Drivers Are Shaping The Development Of The Drug Delivery Devices Market?

The projected expansion of the drug delivery devices market is anticipated to be fueled by rising healthcare expenditures. This spending encompasses the complete financial investment in health-related services and products, covering costs associated with hospitals, doctors, nursing, medications, and public health initiatives. Several factors contribute to this increase, such as an aging demographic, the growing occurrence of chronic illnesses, innovations in medical technology, and elevated expenses for medical care and pharmaceutical products. Greater allocation to healthcare facilitates the advancement of drug delivery devices by channeling more capital into research, pioneering new solutions, and implementing cutting-edge technologies, thereby enhancing treatment effectiveness and patient results. An illustrative example comes from May 2024, when the UK’s Office for National Statistics, a government body, reported that UK healthcare expenditure reached approximately $379 billion (£292 billion) in 2023. This represented a nominal increase of 5.6% over 2022, a substantial jump from the 0.9% growth recorded in 2023. Consequently, the expansion of healthcare spending acts as a primary catalyst for the growth of the drug delivery devices market.

What Segment Types Are Examined In The Drug Delivery Devices Market?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Which Competitive Trends Are Impacting The Structure Of The Drug Delivery Devices Market?

Major companies operating in the drug delivery devices market are focusing on developing advanced solutions like targeted oral release capsules to enhance treatment efficacy and reduce systemic side effects. These capsules are engineered to withstand the acidic environment of the stomach and release active ingredients precisely in specific segments of the gastrointestinal tract, improving bioavailability and localizing therapy. For instance, in September 2024, Evonik, a Germany-based specialty chemicals and life sciences company, launched its new EUDRACAP colon capsules, designed for delivery of sensitive active substances to the ileo-colonic region. These capsules support the administration of live biotherapeutic products, oral biologics, peptides, proteins, and nucleotides while preserving their integrity through tailored EUDRAGIT coatings. The EUDRACAP colon capsules also streamline formulation development with a ready-to-fill design and improve speed to market by reducing complexity in development. This innovation expands Evonik’s EUDRACAP platform and strengthens its system solutions portfolio for advanced oral drug delivery.

Who Are The Core Companies Influencing Trends In The Drug Delivery Devices Market?

Major companies operating in the drug delivery devices market are Becton Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, West Pharmaceutical Services Inc., Gerresheimer AG, Smiths Medical, Elcam Medical, SMC Ltd., Injex, Ypsomed Holding AG, Nemera, H&T Presspart, Syqe Medical, Antares Pharma, Julphar, Teleflex Medical, Kedalion Therapeutics, MediPrint Ophthalmics, Sorrel Medical, Terumo Corporation, Gilero

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Drug Delivery Devices Market?

North America was the largest region in the drug delivery devices market in 2025. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Delivery Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2026, By The Business Research Company

Drug Delivery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Connected Drug Delivery Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/connected-drug-delivery-devices-global-market-report

Pharmaceutical Drug Delivery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795